| 8741/13381 | US=21 / Biol/Mol Cabral F. Mechanisms of resistance to drugs that interfere with microtubule assembly. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 337-56. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. MECANISMOS DE RESISTENCIA A DROGAS QUE INTERFEREM COM A MONTAGEM DE MICROTUBULOS; RESISTENCIA A DROGAS; PACLITAXEL; COLCEMIDA; VINBLASTINA; TUBULINA; MUTACOES; ISOTIPOS |
| 8742/13381 | US=21 / Biol/Mol Giannakakau P, Snyder JP. Resistance to microtubule-targeting drugs. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 357-94. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. RESISTENCIA A DROGAS DE MICROTUBULOS SEGMENTACAO; MICROTUBULOS; RESISTENCIA AS DROGAS; TAXANOS; ALCALOIDES DA VINCA; COLCHICINA; MUTACAO TUBULINA |
| 8743/13381 | US=21 / Biol/Mol Takimoto CH, Beeram M. Microtubule stabilizing agents in clinical oncology. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 395-419. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. MICROTUBULO AGENTES ESTABILIZANTES EM ONCOLOGIA CLINICA; TAXANOS; PACLITAXEL; DOCETAXEL |
| 8744/13381 | US=21 / Biol/Mol Vereshchagina LA, Scharf O, Colevas AD. Investigational anticancer agents targeting the microtubule. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 421-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. INVESTIGACIONAIS AGENTES ANTICANCERIGENOS; SEGMENTACAO DOS MICROTUBULOS; EPOTILONA; DOLOSTATIN; COLCHICINA; AGENTES DE INVESTIGACAO |
| 8745/13381 | US=21 / Biol/Mol Carré M, Braguer D. Microtubule damaging agents and apoptosis. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 479-518. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES NOCIVOS MICROTUBULOS E APOPTOSE; APOPTOSE; MITOCONDRIAS; MICROTUBULOS; CELULA TUMORAL; DROGAS ANTI-CANCER; TAXANO; VINCA ALCALOIDES |
| 8746/13381 | US=21 / Biol/Mol Giavazzi R, Bonezzi K, Taraboletti G. Microtubule targeting agents and the tumor vasculature. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 519-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. AGENTES DE MICROTUBULOS SEGMENTACAO EA VASCULARIZACAO DO TUMOR; INIBIDORES DA ANGIOGENESE; AGENTE DE RUPTURA VASCULAR; CELULAS ENDOTELIAIS; VASCULATURA TUMORAL; TERAPEUTICA DE COMBINACAO |
| 8747/13381 | US=21 / Biol/Mol Delacourte A, Sergeant N, Buée L. Neurodegenerative diseases. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 531-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. DOENCAS NEURODEGENERATIVAS; SPLICING ALTERNATIVO; AXONIOS; MORTE CELULAR; MUTACOES; NEURONIOS; FOSFORILACAO |
| 8748/13381 | US=21 / Biol/Mol Bunker J, Feinstein SC. Structure, function, and regulation of the microtubule associated protein Tau. In: Fojo T. The role of microtubules in cell biology, neurobiology, and oncology. New Jersey: Springer, 2008. p. 559-76. (Cancer Drug Discovery and Development) ISBN 978-1-58829-294-0. MICROBUTULE DINAMICA; NEURODEGERATION; DOENCA DE ALZHEIMER; FTOP-17; DEMENCIA; TAUOPATHY |
| 8749/13381 | US=22 / Odontologia Epstein J, Waal IVD. Oral cancer. In: Greenberg MG, Glick M, Ship JA. Burket's oral medicine. Hamilton: BC Decker, 2008. p. 153-89. ISBN 978-1-55009-345-2. CANCER BUCAL; CARCINOMA DE CELULAS ESCAMOSAS; CANCER CABECA E PESCOCO; PRE-TRATAMENTO ORAL E DENTAL; COMPLICACOES DO TRATAMENTO DO CANCER; DOR NO CANCER OROFACIAL. TRATAMENTO |
| 8750/13381 | US=23 / Biol/Mol Read A, Donnai D. O câncer é genético?. In: ___. Genética clínica: uma nova abordagem. Porto Alegre: Artmed, 2008. p. 293-328. ISBN 85-3631190-6. CANCER; EVOLUCAO DO CANCER; HISTORICO FAMILIAR; ONCOGENES; GENES SUPRESSORES DE TUMOR; CANCER COLORRETAL HEREDITARIO SEM POLIPOSE; DESENVOLVIMENTO DO CANCER; EPIGENETICA NO CANCER; CANCERES FAMILIARES DE MAMA; CANCERES FAMILIARES DE COLORRETAL |
| 8751/13381 | US=23 / Biol/Mol Read A, Donnai D. Devemos testar a suscetibilidade genética para doenças comuns?O câncer é genético?. In: ___. Genética clínica: uma nova abordagem. Porto Alegre: Artmed, 2008. p. 329-61. ISBN 85-3631190-6. |
| 8752/13381 | US=25 / Urologia Sakr W. Defining the problem: from subclinical disease to clinically insignificant prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 1-11. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. |
| 8753/13381 | US=25 / Urologia Stamey TA, Nolley R, Torti D. What every patient should know about prostate cancer before he submits to biopsy of his prostate. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 13-27. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. |
| 8754/13381 | US=25 / Urologia Nielsen ME, Partin AW. The role of complexed prostate-specific antigen in prostate cancer screening. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 29-41. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. PAPEL DO COMPLEXADO ANTIGENO PROSTATICO; RASTREAMENTO DO CANCER DE PROSTATA; ISOFORMAS DE PSA; COMPLEXADO POR CENTO PSA PSA LIVRE |
| 8755/13381 | US=25 / Urologia Canto EI, Slawin KM. Newly recognized forms of prostate-specific antigen and emerging molecular markers. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 43-59. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. ANTIGENO PROSTATICO ESPECIFICO; EMERGENTES MARCADORES MOLECULARES; ANTIGENO ESPECIFICO DA PROSTATA (PSA); FORMAS MOLECULARES DE PSA LIVRE; RASTREIO DO CANCER DA PROSTATA; MALDI-TOF; SELDI-TOF |
| 8756/13381 | US=25 / Urologia Carter HB. The role of prostate-specific antigen velocity in the diagnosis and management of prostate cancer. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 61-70. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. PROSTATICO ESPECIFICO; TRATAMENTO DE CANCER DE PROSTATA; BLINDAGEM; VELOCIDADE DO PSA; PSA TEMPO DE DUPLICACAO; PSA CINETICA |
| 8757/13381 | US=25 / Urologia Brand TC, Thompson IM. Prostate cancer screening: navigating the controversy. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 71-82. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. RASTREIO DO CANCER DA PROSTATA; CANCER DE PROSTATA; ANTIGENIO ESPECIFICO DA PROSTATA; PREVENCAO |
| 8758/13381 | US=25 / Urologia Karakiewicz PI, Kattan MW. Prostate cancer nomograms and how they measure up to neural networks. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 83-96. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. NOMOGRAMAS DE CANCER DE PROSTATA; NOMOGRAMAS; MODELOS DE PREVISAO; REDES NEURAIS; BLINDAGEM |
| 8759/13381 | US=25 / Urologia Terris MK. Principles of prostate ultrasound. In: Jones JS. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 105-19. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. PRINCIPIOS DE ULTRA-SOM DE PROSTATA; CANCER DE PROSTATA. ULTRA-SOM; CANCER DE PROSTATA. HIPOECOICA; CANCER DE PROSTATA. IMAGEM; CANCER DE PROSTATA |
| 8760/13381 | US=25 / Urologia Jones JS. Saturation biopsy for detection and characterization of prostate cancer. In: ___. Prostate biopsy: indications, techniques, and complications. New Jersey: Humana Press, 2008. p. 217-29. (Currrent Clinical Urology) ISBN 978-1-58829-790-7. SATURACAO BIOPSIA CANCER DE PROSTATA; SATURACAO BIOPSIA; BIOPSIA DA PROSTATA; REPETIR A BIOPSIA; PARASSAGITAL; REPETIR A BIOPSIA |